Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
BCRX similar filings
- 5 Nov 19 BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks
- 1 Nov 19 BioCryst Begins Phase 1 Trial With BCX9250, an Oral ALK-2 Inhibitor, for Treatment of Fibrodysplasia Ossificans Progressiva
- 28 Oct 19 BioCryst Reports Data From Phase 1 Trial of BCX9930 and Announces Plans to Advance Program Into Proof of Concept Study in PNH Patients
- 26 Sep 19 U.S. Government Exercises Option for Additonal Rapivab® for Strategic National Stockpile
- 23 Sep 19 BioCryst Appoints Helen Thackray, M.D., to Board of Directors
- 16 Sep 19 Entry into a Material Definitive Agreement
- 6 Aug 19 BioCryst Reports Second Quarter 2019 Financial Results
Filing view
External links